Cite
MLA Citation
Jakub Simon et al.. “28. Immunogenicity of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO™) in Participants by Age, Sex, and Baseline GP-ELISA Titer: A Post Hoc Analysis of Three Phase 2/3 Trials.” Open forum infectious diseases, vol. 7, n.d., p. S38. http://access.bl.uk/ark:/81055/vdc_100121989380.0x000011